Not a Project (Mandated or Core Funding)
Galenvs Sciences Inc.
8 records totalling $2,397,087.00 CAD, from official Government of Canada open data.
Embed this chart
By department
| National Research Council Canada | $1,315,087 | 6 records |
| Health Canada | $1,082,000 | 2 records |
Records
The Firm seeks to advance the state of the art in aptamer drug development through the development of novel chemistries of non-natural or modified natural nucleotides and synthesis and purification me...
As part of the international consortium project “GREEN-MNP-BUFFER," this project will focus on developing next-generation magnetic nanoparticle and buffer formulations using proprietary, sustainable,...
COVID-19 Challenge: To develop a proof of concept for The National Research Council Canada (NRC) is seeking a solution for reagents required for nucleic acid sample preparation and rapid and efficient...
Not a Project (Mandated or Core Funding)
As part of Multinational Corporate Collaboration Program, the project “Development of Functionalized MNPs and Oligonucleotides for Purification and Diagnostics” will focus on advancing technologies fo...
The firm is advancing the development of rapid diagnostic workflows for detecting Haplosporidium nelsoni in oysters, leveraging its expertise in sample preparation using magnetic nanoparticles and sp...
The youth will join the firm's’ oligonucleotide synthesis team to support the development, evaluation, production, and delivery of chemically-modified aptamer sequences and other oligonucleotide thera...